The only FDA cleared non-invasive, continuous blood pressure monitor highly correlated to the arterial line for accuracy

Tomer Bentzion, CEO

Tech Brief

LiveMetric is FDA cleared & offers the full pressure waveform sampled at 100Hz, which means LiveMetric provides the most accurate blood pressure measurements possible outside of the arterial line utilized in the ICU. The full pressure waveform additionally allows for the identification of cardiovascular disease, such as biphasic systole, arrhythmias, morning surge, masked asleep hypertension, and aortic regurgitation to name a few (LiveMetric is currently in clinical trials to identify 20+ conditions). Through the passive wearing of the LiveMetric band, users will have the ability to be monitored for CVD that is currently only available to find/diagnose through ECHO, labs, and a complaint to their provider. No other technology has the ability to capture the full pressure waveform. LiveMetric is based on MEMS nanosensor technology which means we measure actual pressure, and not an estimation of pressures, as seen with PPG sensors and cuffs. By measuring actual pressure the provider can rely on results taken at home, and bypass the need to verify a patient's measurements by taking measurements in office. Through hundreds of measurements taken within days a provider can titrate medicine within a week vs. the typical 6-9 timeframe that medication titration currently takes. LiveMetric utilizes AI/ML algorithms to ensure the accuracy of every reading and an inaccurate reading will never be provided to the user or provider, such as can be seen with a cuff or PPG sensor. These algorithms alongside our sensor technology make LiveMetric the only BP monitor on the market that does not require calibration.

Problem Tech Solves

Cardiovascular disease (CVD) is the #1 killer in the US. The largest global epidemic known to mankind, hypertension (HTN), or high blood pressure (BP), is the main preventable contributor to numerous major health conditions such as heart attack, kidney failure & stroke. At least 1/3 US adults have HTN, yet almost HALF of them don't have their BP controlled. Only 7% of all BP monitors are validated for clinical accuracy, primarily because a cuff provides, at best, an approximation of BP, rather than actual pressure readings such as those taken by ICU-grade arterial lines. Cuffs are also painful to use users must stop activity to take readings and, even then, only see daytime readings, leading to low patient engagement for monitoring BP. Without continuous, accurate, passive monitoring, neither the patient nor the provider can manage HTN or CVD with the quality outcomes required to reduce the population of uncontrolled hypertensives.


Several studies are underway to demonstrate the use of CPT reimbursement codes with the LiveMetric platform to demonstrate driving new revenues as well as studies to demonstrate less use of the ED for hypertensive urgency and CHF readmissions. Each study is approx. 30-50 subjects and include a hospital, employer and payer.